Pharma Journalist -

SMi Group are proud to present the 6th Annual Antibodies & Antibody Drug Conjugates conference, taking place on the 9th - 10th April, 2018 at the Copthorne Tara Hotel London, UK.…
Read More...

Join SMi Group in London on 11th & 12th April 2018 for the 14th annual conference on Asthma & COPD to discuss ways of improving health outcomes and revolutionising clinical…
Read More...

Perrigo Company declared having sought tentative U.S FDA approval for the generic version of Soolantra cream,1%. Soolantra cream implied for the treatment of inflammatory lesions of…
Read More...

CorePharma acquired by Investor Group, its facilities and equipment in Middlesex, NJ from Impax Laboratories. Financial terms of the acquisition were not disclosed. The acquisition does…
Read More...

Microbiome comapany developing customized phage therapies , BiomX Ltd. declared that it has sought sub-license from JSR Corporation a set of bacterial targets for the development and…
Read More...

Clinical-stage biotechnology company,devoted to treating inflammation and inborn errors of metabolism, Aldeyra Therapeutics enrolled first patient in a Phase 2b Clinical Trial of …
Read More...

Upsher-Smith Laboratories, LLC  declared that it sought U.S Food and Drug Administration's approval for new drug application (ANDA) for Bumetanide Tablets, USP, 0.5 mg, 1 mg, and 2 mg,…
Read More...

Industry leader in orthopaedic devices using advanced functional materials, MedShape declared successful performance of first surgeries using DynaNail XL TTC Fusion System.  The…
Read More...

Mallinckrodt plc affirmed enrolling first patient in the company's Phase 4, multi center, randomized, double-blind, placebo-controlled pilot study to facilitate evaluation of the…
Read More...

U.S  Food and Drug Administration conceded to Multi  Radiance Medical's MR4 Laser technology for neck and shoulder pain relief under the Product Classification NHN. MR4 Laser technology…
Read More...